Grifols (GRFS) Exchange Rate Effect (2009 - 2020)
Grifols' (GRFS) quarterly Exchange Rate Effect came in at $15.1 million in Q1 2020, down 32.13% YoY from $22.3 million in Q2 2019, and down 73.68% on a QoQ basis from $57.4 million in Q4 2019.
Grifols (GRFS) Exchange Rate Effect (2009 - 2020) Analysis & Trends
Grifols (GRFS) has 12 years of Exchange Rate Effect data on file, last reported at $15.1 million in Q1 2020.
- Quarterly Exchange Rate Effect fell 32.13% year-over-year to $15.1 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $128.3 million (up 54.98% YoY) and the FY2025 annual result came in at -$109.4 million, down 565.44% from the prior year.
- Exchange Rate Effect declined to $15.1 million in Q1 2020, from $57.4 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $66.1 million in Q4 2016 to a low of -$102.1 million in Q4 2017.
- A 5-year average of -$12738.7 and a median of $15.1 million in 2020 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2016 — Exchange Rate Effect plunged 1215.1% — and 2019, when it surged 180.34%.
- Tracing GRFS's Exchange Rate Effect over 5 years: stood at $66.1 million in 2016, then plunged by 254.32% to -$102.1 million in 2017, then jumped by 132.8% to $33.5 million in 2018, then surged by 71.52% to $57.4 million in 2019, then sank by 73.68% to $15.1 million in 2020.
- The last three Exchange Rate Effect figures came in at $15.1 million (Q1 2020), $57.4 million (Q4 2019), and $22.3 million (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 9.00 Mn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -19.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -4.00 Mn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 15.12 Mn |
| Mar 31, 2020 | 15.12 Mn |
| Dec 31, 2019 | 57.43 Mn |
| Dec 31, 2019 | 57.43 Mn |
| Mar 31, 2019 | 22.27 Mn |
| Mar 31, 2019 | 22.27 Mn |
| Dec 31, 2018 | 33.48 Mn |
| Dec 31, 2018 | 33.48 Mn |
| Jun 30, 2018 | 54.75 Mn |
| Jun 30, 2018 | 54.75 Mn |
| Mar 31, 2018 | -27.72 Mn |
| Mar 31, 2018 | -27.72 Mn |
| Dec 31, 2017 | -102.07 Mn |
| Dec 31, 2017 | -102.07 Mn |
| Jun 30, 2017 | -79.63 Mn |
| Jun 30, 2017 | -79.63 Mn |
| Mar 31, 2017 | 11.32 Mn |
| Mar 31, 2017 | 11.32 Mn |
| Dec 31, 2016 | 66.14 Mn |
| Dec 31, 2016 | 66.14 Mn |